Kiryat-Haim, Israel

Mariana Hainrichson

USPTO Granted Patents = 5 


 

Average Co-Inventor Count = 5.0

ph-index = 3

Forward Citations = 18(Granted Patents)


Location History:

  • Kiryat-Haim, IL (2014 - 2015)
  • Kiryat-Yam, IL (2017 - 2018)

Company Filing History:


Years Active: 2014-2018

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations of Mariana Hainrichson

Introduction

Mariana Hainrichson is a notable inventor based in Kiryat-Haim, Israel. She has made significant contributions to the field of genetic disorders through her innovative research and development. With a total of 5 patents, her work focuses on aminoglycosides and their applications in treating genetic conditions.

Latest Patents

Hainrichson's latest patents include a new class of paromomycin-derived aminoglycosides. These compounds exhibit efficient stop-codon mutation suppression activity, low toxicity, and high selectivity towards eukaryotic cells. The patents also detail chemical and chemo-enzymatic processes for preparing these aminoglycosides and their intermediates. Additionally, pharmaceutical compositions containing these compounds are described, along with their uses in the treatment of genetic disorders.

Career Highlights

Mariana Hainrichson is affiliated with the Technion Research & Development Foundation Limited, where she continues to advance her research. Her work has garnered attention for its potential impact on the treatment of genetic disorders, showcasing her dedication to innovation in the field.

Collaborations

Hainrichson collaborates with esteemed colleagues, including Timor Baasov and Tamar Ben-Yosef. These partnerships enhance her research efforts and contribute to the development of groundbreaking solutions in genetic medicine.

Conclusion

Mariana Hainrichson's contributions to the field of genetic disorders through her innovative patents highlight her role as a leading inventor. Her work not only advances scientific knowledge but also holds promise for improving patient outcomes in the treatment of genetic conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…